The British Journal of Dermatology | 2019
A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis
Abstract
Patients recruited in randomized controlled trials (RCTs) for biologic therapies in psoriasis are not fully representative of the real‐world psoriasis population.